The Berlin questionnaire is used to screen for risk of which sleep disorder?

The Berlin questionnaire is used to screen for risk of which sleep disorder?

• A. Obstructive sleep apnea
• B. Narcolepsy
• C. Restless legs syndrome
• D. Insomnia

Answer: (A)

Screening for obstructive sleep apnea. The Berlin questionnaire is designed to identify people who are at high risk for OSA by looking at three areas: how loudly and how often you snore and whether others notice witnessed apneas, your daytime sleepiness or fatigue, and whether you have hypertension or obesity. If two of these areas are positive, you’re considered high risk for OSA, which helps guide whether you should pursue diagnostic testing like polysomnography. It isn’t meant to diagnose narcolepsy, restless legs syndrome, or insomnia. Narcolepsy centers on excessive daytime sleepiness with features like cataplexy; restless legs syndrome involves uncomfortable sensations in the legs and an urge to move; insomnia is difficulty with sleep initiation or maintenance. These conditions are typically screened or diagnosed with different tools and criteria, not the Berlin questionnaire.

Screening for obstructive sleep apnea. The Berlin questionnaire is designed to identify people who are at high risk for OSA by looking at three areas: how loudly and how often you snore and whether others notice witnessed apneas, your daytime sleepiness or fatigue, and whether you have hypertension or obesity. If two of these areas are positive, you’re considered high risk for OSA, which helps guide whether you should pursue diagnostic testing like polysomnography.

It isn’t meant to diagnose narcolepsy, restless legs syndrome, or insomnia. Narcolepsy centers on excessive daytime sleepiness with features like cataplexy; restless legs syndrome involves uncomfortable sensations in the legs and an urge to move; insomnia is difficulty with sleep initiation or maintenance. These conditions are typically screened or diagnosed with different tools and criteria, not the Berlin questionnaire.